Malignant Neoplasm of Unknown Primary — Trials

Malignant Neoplasm of Unknown Primary — Trials · CancerIndex

Clinical trials

Registered studies

14,253 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 4,158
Recruiting: 2,260
Ph III recruiting: 268
Growth YoY: +13.9%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,895)

clinicaltrialsPublishedShowing 4,801–4,808 of 4,808 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00273247	Treatment With IFN After Curative Resection of HCC in HCV-Related Cirrhosis	completed	Phase 3	150	National Cancer Institute, MilanOTHER	1	Jan 9, 2006	clinicaltrials
NCT00149565	Phase Ⅲ Randomized Trial in Postoperative Hepatocellular Carcinoma	completed	Phase 3	268	National Health Research Institutes, TaiwanOTHER	1	Dec 16, 2005	clinicaltrials